Lidocaine-induced cell death in a human model of neuronal apoptosis

European Journal of Anaesthesiology

Volumn 19, Issue 8, 2002, Pages 564-570

  Friederich, P ^a   Schmitz, T P ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Anaesthesia conduction, anaesthesia local; Anaesthetics, local, lidocaine; Cell death, apoptosis; Cell death, necrosis; Neurotoxins

Indexed keywords

ANESTHETIC AGENT; LACTATE DEHYDROGENASE; LIDOCAINE; RETINOIC ACID; TRYPAN BLUE;

APOPTOSIS; ARTICLE; CELL COUNT; CELL DEATH; CELL DIFFERENTIATION; CELL POPULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NERVE CELL; NEUROLOGIC DISEASE; NEUROTOXICITY; STAINING; TIME; BIOSYNTHESIS; CELL LINE; CYTOLOGY; DRUG EFFECT; IMMUNOCHEMISTRY; METABOLISM;

APOPTOSIS; CELL LINE; FLOW CYTOMETRY; HUMANS; IMMUNOCHEMISTRY; L-LACTATE DEHYDROGENASE; LIDOCAINE; NEURONS;

EID: 0036023260     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003643-200208000-00004     Document Type: Article

References (28)

1. Transient neurologic symptoms after spinal anesthesia
2. Prospective study of the incidence of transient radicular irritation in patients undergoing spinal anesthesia
3. Serious complications related to regional anesthesia: Results of a prospective survey in France
4. Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine
5. Cauda equina syndrome following a single spinal administration of 5% hyperbaric lidocaine through a 25-gauge Whitacre needle
6. Cauda equina syndrome after continuous spinal anesthesia
7. Irreversible conduction block in isolated nerve by high concentrations of local anesthetics
8. Concentration dependence of lidocaine-induced irreversible conduction loss in frog nerve
9. Graded, irreversible changes in crayfish giant axon as manifestations of lidocaine neurotoxicity in vitro
10. Lidocaine toxicity in primary afferent neurons from the rat
11. Lidocaine disrupts axonal membrane of rat sciatic nerve in vitro
12. Does pregnancy protect against intrathecal lidocaine-induced transient neurologic symptoms?
13. Transient neurologic symptoms after spinal anesthesia with lidocaine in obstetric patients
14. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: Involvement of the glutathione system
15. Studies on the neurotoxicity of 6,7-dihydroxy-l-methyl-1,2,3,4-tetrahydroisoquinoline (salsolinol) in SH-SY5Y cells
16. Cisplatin induces apoptosis in Sh-SY5Y human neuroblastoma cell line
17. Cytotoxicity of endogenous isoquinolines to human dopaminergic neuro blastoma SH-SY5Y cells
18. R(-)-deprenyl potentiates dopamine-induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells
19. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture
20. Retinoic acid-induced differentiation of cultured human neuroblastoma cells: A comparison with phorbol ester induced differentiation
21. The neurotoxic effect of 24-hydroxycholesterol on SH-SY5Y human neuroblastoma cells
22. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture
23. Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods
24. Retinoic acid induces apoptosis-associated neural differentiation of a murine teratocarcinoma cell line
25. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma
26. Staurosporine induces a neuronal phenotype in SH-SY5Y human neuroblastoma cells that resembles that induced by the phorbol ester 12-O-tetradecanoyl phorbol-13 acetate (TPA)
27. Protein synthesis and mRNA in isolated growth cones from differentiating SH-SY5Y neuroblastoma cells
28. Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: Involvement of bcl-2 and p53 proteins